Is Agilent Technologies, Inc. overvalued or undervalued?

As of 17 October 2025, Agilent Technologies, Inc. moved from very expensive to fair in its valuation grade. Based on the current metrics, the company appears fairly valued. The P/E ratio stands at 25, while the EV to EBITDA ratio is 18.73, and the Price to Book Value is 5.36. In comparison, peers such as Edwards Lifesciences Corp. have a higher P/E ratio of 31.17, indicating that Agilent is relatively more attractively priced within its sector.
Despite a recent underperformance compared to the S&P 500, with a 1-year return of 3.27% versus 14.08% for the index, Agilent's valuation metrics suggest it is positioned well against its peers, making it a potentially appealing investment at its current price of 141.92.